FIELD: chemistry.
SUBSTANCE: invention concerns intermediates for the synthesis of halichondrins (for example, halichondrin A, B, C; homohalichondrin A, B, C; norhalichondrin A, B, C) and their analogues, as well as methods for preparing these intermediates. In particular, the present invention relates to methods and compounds useful for the synthesis of a compound with formula (H3-A).
EFFECT: compounds and methods applicable to synthesis of the compound (1) are also disclosed.
79 cl, 41 dwg
Title | Year | Author | Number |
---|---|---|---|
SULFONYL UREA AND RELATED COMPOUNDS AND USE THEREOF | 2016 |
|
RU2739356C2 |
β-D-2ʹ-DEOXY-2ʹ-α-FLUORO-2ʹ-β-C-SUBSTITUTED-2-MODIFIED-N6-SUBSTITUTED PURINE NUCLEOTIDES FOR TREATMENT OF DISEASES CAUSED BY HCV | 2016 |
|
RU2764767C2 |
PYRIMIDINE-2,4-DIAMINE DERIVATIVES FOR CANCER TREATMENT | 2013 |
|
RU2672916C2 |
SULPHONYLUREAS AND RELATED COMPOUNDS AND THEIR USE | 2016 |
|
RU2795512C2 |
HETEROCYCLIC MUSCARINIC AGONISTS AND COMPOSITIONS, THEIR USING AND METHODS FOR TREATMENT | 2002 |
|
RU2292346C2 |
VAR2CSA-DRUG CONJUGATES | 2014 |
|
RU2714933C2 |
SERIN / TREONIN KINASE INHIBITORS FOR TREATING OF HYPEROPLIFERATIVE DISEASES | 2013 |
|
RU2644947C2 |
DERIVATIVES OF BENZIMIDAZOLIDINONE AS AGENTS FOR MUSCARINIC RECEPTORS | 2002 |
|
RU2288919C2 |
DERIVATIVES OF 3-OXO-1-CYCLOBUTENE AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 2002 |
|
RU2296753C2 |
PYRAZOLOPYRIDINE DERIVATIVES AS KINASE INHIBITORS | 2015 |
|
RU2733400C2 |
Authors
Dates
2023-04-12—Published
2018-07-06—Filed